Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Lenalidomide × Clear all

Phase

Phase 2 9 Phase 3 2 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Recruiting 3 Completed 3 Withdrawn 1 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

anlotinib 5 lenvatinib 4 Oxaliplatin 4 Carboplatin 4 Prednisone 3 Immune Checkpoint Inhibitors 3 Dexmedetomidine 3 Dexamethasone 3 Cisplatin 3 venetoclax 2 sintilimab 2 Rosuvastatin Calcium 2 Leucovorin 2 Injections 2 Indocyanine Green 2 Fluorouracil 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 Aspirin 2 zanubrutinib 1 xiaojin wan 1 trastuzumab deruxtecan 1 trametinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 tenofovir alafenamide 1 telitacicept 1 talquetamab 1 talniflumate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07334535 2026-01-13

Isa-VRD in TIE HRMM

Peking Union Medical College Hospital

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡